160 related articles for article (PubMed ID: 31567954)
41. Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.
Garnæs E; Mortensen C; Hobolth L; Andersen O; Nehlin J; Møller S
PLoS One; 2019; 14(8):e0220697. PubMed ID: 31465463
[TBL] [Abstract][Full Text] [Related]
42. Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
Burcsár S; Toldi G; Kovács L; Szalay B; Vásárhelyi B; Balog A
Biomarkers; 2021 Jul; 26(5):443-449. PubMed ID: 33825610
[TBL] [Abstract][Full Text] [Related]
43. Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.
Kokkinos A; Liaskos C; Alexiadou K; Papassotiriou I; Margeli A; Argyrakopoulou G; Perrea D; Alexandrou A; Katsilambros N; Diamantis T; Tentolouris N
J Endocrinol Invest; 2021 Mar; 44(3):599-608. PubMed ID: 32681464
[TBL] [Abstract][Full Text] [Related]
44. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.
Bock ME; Price HE; Gallon L; Langman CB
Clin J Am Soc Nephrol; 2013 Aug; 8(8):1304-11. PubMed ID: 23620441
[TBL] [Abstract][Full Text] [Related]
45. Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus.
Toldi G; Szalay B; Bekő G; Bocskai M; Deák M; Kovács L; Vásárhelyi B; Balog A
Biomarkers; 2012 Dec; 17(8):758-63. PubMed ID: 23033975
[TBL] [Abstract][Full Text] [Related]
46. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery.
Mossanen JC; Pracht J; Jansen TU; Buendgens L; Stoppe C; Goetzenich A; Struck J; Autschbach R; Marx G; Tacke F
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758975
[TBL] [Abstract][Full Text] [Related]
47. Plasma Level of Soluble Urokinase-type Plasminogen Activator Receptor Predicts the Severity of Acute Alcohol Pancreatitis.
Nikkola A; Aittoniemi J; Huttunen R; Rajala L; Nordback I; Sand J; Laukkarinen J
Pancreas; 2017 Jan; 46(1):77-82. PubMed ID: 27841794
[TBL] [Abstract][Full Text] [Related]
48. Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis?
Pawlak K; Ulazka B; Mysliwiec M; Pawlak D
Transl Res; 2012 Nov; 160(5):346-54. PubMed ID: 22683425
[TBL] [Abstract][Full Text] [Related]
49. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
50. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
[TBL] [Abstract][Full Text] [Related]
51. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
[TBL] [Abstract][Full Text] [Related]
52. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
53. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.
Okulu E; Arsan S; Akin IM; Ates C; Alan S; Kilic A; Atasay B
J Clin Lab Anal; 2015 Sep; 29(5):347-52. PubMed ID: 25043869
[TBL] [Abstract][Full Text] [Related]
54. [Can mannose-binding lectin and plasma level of soluble urokinase receptor be used in diagnosis and treatment monitorization of brucellosis patients?].
Karsen H; Cesur S; Karaağaç L; Binici I; Fidan Y; Oğüş E; Demiröz AP
Mikrobiyol Bul; 2012 Jul; 46(3):519-21. PubMed ID: 22951667
[TBL] [Abstract][Full Text] [Related]
55. Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects.
El-Patal MA; Khalil MA; Shipl W; Barakat I; Youssef EMI; El Attar S; Fathi A; Abdallah AA
BMC Oral Health; 2022 Oct; 22(1):436. PubMed ID: 36192745
[TBL] [Abstract][Full Text] [Related]
56. Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Systemic Lupus Erythematosus Patients.
Zaitoon YA; Shehab AA; Mohamed NA; Morad CS; Yassine EM
Egypt J Immunol; 2018 Jan; 25(1):35-43. PubMed ID: 30242996
[TBL] [Abstract][Full Text] [Related]
57. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
[TBL] [Abstract][Full Text] [Related]
58. Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection.
Berres ML; Schlosser B; Berg T; Trautwein C; Wasmuth HE
J Clin Gastroenterol; 2012 Apr; 46(4):334-8. PubMed ID: 21934527
[TBL] [Abstract][Full Text] [Related]
59. Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia.
Tsai PK; Tsao SM; Yang WE; Yeh CB; Wang HL; Yang SF
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30901954
[TBL] [Abstract][Full Text] [Related]
60. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
